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Four forms of nephrocalcin have been routinely isolated from mammalian kidney tissues and urine using DEAE-cellulose 
column chromatography with a linear NaCl gradient. We have demonstrated that these four forms of nephrocalcin, 
isolated from bovine kidneys, contain different amounts of phosphate residues, and that alkaline phosphatase digestion 
converts these to only one form of nephrocalcin. The changes in the nephrocalcin before and after removal of phosphate 
residues were measured by 3’P-NMR spectrometer. Loss of phosphate residues decreased the dissociation constant of 
nephrocalcin IO-fold toward calcium oxalate monohydrate crystals, suggesting the phosphate residues appear to be im- 
portant in the inhibitory effects of calcium oxalate monohydrate crystal growth. 
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1. INTRODUCTION 
Nephrocalcin, an acidic urinary glycoprotein in- 
hibitor of calcium oxalate monohydrate crystal 
growth (kidney stone inhibitor), has been isolated 
from normal human urine [l], the urine of kidney 
stone formers [2], kidney stones [3], rat urine and 
kidney tissues [4], and human kidney tissue culture 
media [5]. This inhibitor usually elutes in four dif- 
ferent ionic strength regions during DEAE- 
cellulose column chromatography using a linear 
NaCl gradient, and the amino acid compositions 
of the material in all four regions are identical. By 
amino acid analysis [l], all four forms contain 
phosphoserine and variable numbers of y- 
carboxyglutamic acid (Gla) residues. Nephro- 
calcins isolated from the urine of kidney stone 
formers [2] and from kidney stones did not contain 
Gla [3]. 
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The different amounts of the phosphoserine and 
Gla residues were not sufficient to explain why 
these inhibitors eluted at widely different ionic 
strength during DEAE-cellulose column chro- 
matography. We report here that the phosphate 
contents of each of the four elution peaks differ; 
also we report 31P-NMR results before and after 
incubation with alkaline phosphatase and glyco- 
sidases to remove phosphate and carbohydrate 
residues, respectively. These results indicate that 
variations in the degree of phosphorylation ac- 
count for heterogeneity of elution from DEAE 
cellulose column. 
2. EXPERIMENTS 
2.1. Materials 
Nephrocalcin was purified from bovine kidneys in a manner 
similar to that described for purification from rat kidneys [4]. 
Alkaline phosphatase was in an insoluble form (25 units, Lot 
NoS5F-9550), purchased from Sigma. Mixed glycosidases (Lot 
No.13A) were obtained from Miles Laboratory. Sephacryl 
S-200 was purchased from Pharmacia and packed in a 2 x 
110 cm glass column. DEAE-cellulose was obtained from 
Pierce Chemicals Co. and cycled with 0.5 M HCI and 0.5 M 
NaOH, then equilibrated in 0.05 M Tris-HCl, 0.1 M NaCI, pH 
7.3, before use. 
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2.2. Analytical methods Table 1 
Phosphate was determined by the Fiske-Subbarow method 
after ashing [a]; 0.01 M KHaPO4 was used for preparing a 
calibration curve. Calcium oxalate crystal growth inhibition ac- 
tivity was measured by incorporation rate of [‘4C]oxalate into 
preformed calcium oxalate seed crystals [l]. The dissociation 
constant for inhibitor-crystal interaction was determined by a 
spectrophotometric assay [7]. The proton-decoupled “P-NMR 
spectrum was recorded on a Brucker 200 MHz FT-NMR spec- 
trophotometer at 80.02 MHz in 99% D20 as the solvent at an 
ambient temperature. Typically, an 8 ps pulse followed by 
0.41 s acquisition with 1 s pulse delay was employed. The 
chemical shift was calibrated by using 85% H3P04 as the exter- 
nal standard. 
Phosphate contents and dissociation constants of nephrocalcin 
fractions 
Sample Phosphate content 
bg/mg protein) (G 
Fraction A 48.5 8.45 x lo-* 
Fraction B 470.6 !.lO x 10-7 
Fraction C 1338.5 2.18 x 1O-7 
Fraction D 1931.0 
Fraction C after alkaline 
Nephrocalcin, 13 mg, was dissolved in 4 ml of 0.1 M sodium 
acetate, pH 5.0, and 2 mg of mixed glycosidases were added, 
followed by incubation overnight at 37°C. The solution was 
subjected to a Sephacryl S-200 column, and proteins were 
eluted using 0.02 M Tris-HCl, 0.2 M NaCl, pH 7.3, as a sol- 
vent. The elution of protein was monitored at 280 or 230 nm 
absorbance. For alkaline phosphatase digestion, 13 mg of 
nephrocalcin was dissolved in 4 ml of 0.2 M Tris-HCI, pH 8.0, 
and 12.5 units of insoluble alkaline phosphatase were added 
twice at 6 h intervals during a 12 h incubation at 37°C. The 
solution was centrifuged at 12000 x g, then chromatographed 
on a Sephacryl S-200 column. 
phosphatase digestion 
Fraction C after 
614.5 2.30 x 1O-6 
glycosidase digestion 168.0 
3. RESULTS 
The elution pattern of bovine kidney tissue in- 
hibitors from DEAE-cellulose chromatography as 
previously reported [l-5] is shown in fig. 1. The in- 
hibitor fractions were eluted at A (12-15 mS), B 
(16-22 mS), C (23-28 mS) and D (29-40 mS) at 
increasing NaCl concentrations (fig. 1). Phosphate 
content increased from A to D fraction (table 1). 
The C fraction was incubated with alkaline 
phosphatase and rechromatographed on a DEAE- 
cellulose column with a linear NaCl gradient 
(because of high concentration of protein required 
for NMR studies, we used the most abundant frac- 
tion). The protein was eluted at lo-14 mS (fig.2). 
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Fig. 1. Elution profile of nephrocalcin from DEAE-cellulose 
column. Bovine kidney homogenate was prepared by a similar 
manner as described previously [4], and four fractions of 
nephrocalcin were separated by DEAB-cellulose column 
chromatography (2 x 15 cm) using a linear NaCl gradient from 
0.1 M to 0.5 M in 0.05 M Tris-HCl, pH 7.3. 
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Fig.2. Elution pattern of dephosphorylated nephrocalcin 
fraction C. Fraction was dephosphorylated by alkaline 
phosphatase and chromatographed under the identical 
conditions described in fig. 1. 
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Fig.3. NMR spectrum of nephrocalcin fraction C. The experimental details are described in the text. 
After deglycosylation by glycosidases, the protein 
was similarly eluted at 13-15 mS (not shown). 
The removal of phosphate by alkaline 
phosphatase decreased the dissociation constant 
lo-fold (table 1). The removal of carbohydrate 
caused precipitation of the protein. The 31P-NMR 
spectrum of the original fraction C is shown in 
fig.3. The chemical shifts were + 1.75 ppm, 
- 0.76 ppm and - 1.16 ppm. After alkaline 
phosphatase digestion, the chemical shift at 
+ 1.75 ppm disappeared, but +0.45 ppm was 
observed (not shown). After deglycosylation, 
- 0.86 ppm and - 1.26 ppm were observed (not 
shown). 
4. DISCUSSION 
Multiple forms of nephrocalcin eluted from a 
DEAE-cellulose column with a linear NaCl gra- 
dient suggesting a difference in negative charge. 
Amino acid analyses of four fractions were iden- 
tical [2], and different amounts of Gla in each frac- 
tion were not enough to account for this elution 
pattern. The results presented in this report in- 
dicate that number of phosphate residues per 
nephrocalcin molecule can vary; the more 
phosphorylated forms eluted from DEAE- 
cellulose column at a higher salt concentration. 
Substantial amount of phosphate residues re- 
mained after alkaline phosphatase digestion, in- 
dicating that a phosphate group is present on other 
amino acid residues in addition to serine. 
Deglycosylation decreased phosphate content 
more than alkaline phosphatase digestion. These 
results suggest that a carbohydrate moiety of 
nephrocalcin could also be phosphorylated. It was 
observed that the removal of carbohydrate caused 
precipitation of the protein portion of 
nephrocalcin unless the suspension was made 
alkaline by N-ethylmorpholine. The exact function 
and type of the phosphorylated sugars in 
nephrocalcin are presently unknown; however, it 
appears that at least a conformational difference 
of nephrocalcin may be associated with phos- 
phorylated sugars. 
It is known that phosphoserine is essential for 
biological calcifications: for example, proline-rich 
protein in saliva [8,9], phosphophoryn in dentin 
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matrix [lO,ll], and acidic phosphoprotein in 
mollusk shells [12] contain phosphoserine. We 
determined that phosphoserine residues are present 
in urinary calcium oxalate crystal growth inhibitor, 
nephrocalcin. Dephosphorylation of serine caused 
a lo-fold decrease in the dissociation constant 
toward calcium oxalate monohydrate crystals. We 
conclude that the phosphorylation of serine 
residues may be important in the binding of 
nephrocalcin to calcium oxalate monohydrate 
crystals. 
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